EC HEALTHCARE (HKEX: 02138) has released its financial results for the fiscal year ended March 31, 2026. The company reported total revenue of roughly HK$3.77 billion, representing a decline of 8.9% year-over-year. The loss attributable to equity shareholders widened significantly to approximately HK$403 million, an increase of about 141% compared to the previous year. This resulted in a loss per share of 34 HK cents.

The company attributed the decrease in revenue to several key factors. These include weak demand in certain non-essential healthcare, aesthetic medicine, beauty and wellness categories due to cautious consumer spending and a loss of cross-border consumption. Furthermore, the continued recovery of outbound travel by Hong Kong residents impacted local customer traffic for certain self-paid healthcare and wellness services during holiday periods. The full-year effect of the strategic disposal of several medical service assets in the previous fiscal year also contributed, as revenue from these entities is no longer consolidated into the group's results for the reporting period.